03390.HK
Tycoon Group Holdings Limited
HKSE · Healthcare · Medical - Pharmaceuticals · HK
HKD 0.25
−0.40%Year over year
Reported trailing growth
- Revenue
- +13.8%
- EBITDA
- +455.6%
- EBIT
- +466.5%
- EPS
- +208.9%
- Free cash flow
- +160.2%
- Operating cash flow
- +163.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -2.6%
- EBITDA
- -12.3%
- EBIT
- -12.5%
- Net income
- -29.0%
- EPS
- -30.6%
- Free cash flow
- +247.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026